# A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension

> **NCT02742649** · PHASE1,PHASE2 · COMPLETED · sponsor: **ForSight Vision5, Inc.** · enrollment: 55 (actual)

## Conditions studied

- Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Fixed Combination
- **DRUG:** Bimatoprost
- **DRUG:** Timolol
- **DEVICE:** Placebo Segment
- **DRUG:** Timolol 0.5%

## Key facts

- **NCT ID:** NCT02742649
- **Lead sponsor:** ForSight Vision5, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-30
- **Primary completion:** 2016-12-31
- **Final completion:** 2016-12-31
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2019-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02742649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02742649, "A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02742649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*